Patent · US Active

Stents with drug-containing amphiphilic polymer coating

US8512733B2 · kind B2 · utility

1Cited by
4References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 18, 2010
Grant dateAug 20, 2013
Priority date
Expiry dateJul 9, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2300/606
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

It is provided an intravascular stent comprising a metal body and a coating comprising a polymer and a restenosis inhibiting agent in which the restenosis inhibiting agent is a sparingly water soluble drug and the polymer in the coating is a cross-linked amphiphilic polymer, wherein the amphiphilic polymer comprises groups conferring hydrophobicity and groups conferring hydrophilicity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.